References
- Quinn DM. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev 1987;87:955–79
- Schweitzer ES. Regulated and constitutive secretion of distinct molecular forms of acetylcholinesterase from PC12 cells. J Cell Sci 1993;106:731–40
- Gocer H, Topal F, Topal M, et al. Acetylcholinesterase and carbonic anhydrase isoenzymes I and II inhibition profiles of taxifolin. J Enzyme Inhib Med Chem 2016;31:441–7
- Topal M, Gocer H, Topal F, et al. Antioxidant, antiradical, and anticholinergic properties of cynarin purified from the Illyrian thistle (Onopordum illyricum L.). J Enzyme Inhib Med Chem 2016;31:266–75
- Cheung J, Rudolph MJ, Burshteyn F, et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 2012;55:10282–6
- Pomponi M. The role of TRP84 in catalytic power and the specificity of AChE. Biophys Chem 1998;72:239–46
- Johnson G, Moore SW. The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design. Curr Pharm Des 2006;12:217–25
- Pathak AK, Bandyopadhyay T. Unbinding free energy of acetylcholinesterase bound oxime drugs along the gorge pathway from metadynamics-umbrella sampling investigation. Proteins 2014;82:1799–818
- Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res 2011;221:334–40
- Cochrane M, Cochrane A, Jauhar P, et al. Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome-three further cases show response to donepezil. Alcohol Alcohol 2005;40:151–4
- Arciniegas DB, Silver JM. Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol 2006;17:25–42
- Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011;10:698–712
- Colovic MB, Krstic DZ, Lazarevic-Pasti TD, et al. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 2013;11:315–35
- Main AR, Hastings FL. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine. Science 1966;154:400–2
- Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res 2013;36:375–99
- Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95
- D’Ascenzio M, Chimenti P, Gidaro MC, et al. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies. J Enzyme Inhib Med Chem 2015;30:908–19
- Friggeri L, De Vita D, Pandolfi F, et al. Design, synthesis and evaluation of 3,4-dihydroxybenzoic acid derivatives as antioxidants, bio-metal chelating agents and acetylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2015;30:166–72
- Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimera: a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12
- Zoete V, Cuendet MA, Grosdidier A, et al. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 2011;32:2359–68
- Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 2011;39:W270–7
- Doorn JA, Gage DA, Schall M, et al. Inhibition of acetylcholinesterase by (1S,3S)-isomalathion proceeds with loss of thiomethyl: kinetic and mass spectral evidence for an unexpected primary leaving group. Chem Res Toxicol 2000;13:1313–20
- Masson P, Lushchekina SV. Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance. Arch Biochem Biophys 2016;593:60–8